HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ramadasan Kuttan Selected Research

Oral Administration

1/2016Amelioration of Doxorubicin-Induced Cardiac and Renal Toxicity by Oxycarotenoid Lutein and Its Mechanism of Action.
1/2015Gastroprotective activity of essential oils from turmeric and ginger.
3/2013Acute and subchronic toxicity as well as mutagenic evaluation of essential oil from turmeric (Curcuma longa L).
1/2013Anticarcinogenic activity of meso-zeaxanthin in rodents and its possible mechanism of action.
7/2012Amelioration of cisplatin-induced toxicity in mice by carotenoid meso-zeaxanthin.
1/2012Carotenoid lutein protects rats from gastric ulcer induced by ethanol.
8/2010Antioxidant activity of carotenoid lutein in vitro and in vivo.
9/2009Inhibition of viral carcinogenesis by Phyllanthus amarus.
2/2009Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action.
1/2008Immunostimulatory action of AC II--an ayurvedic formulation useful in HIV.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ramadasan Kuttan Research Topics

Disease

18Body Weight (Weight, Body)
01/2016 - 07/2002
13Neoplasms (Cancer)
01/2013 - 12/2002
4Inflammation (Inflammations)
01/2013 - 03/2003
3Ulcer
01/2017 - 01/2012
3Edema (Dropsy)
07/2015 - 08/2003
3Stomach Ulcer (Gastric Ulcer)
03/2015 - 01/2012
3Carcinogenesis
07/2013 - 04/2006
3Hepatocellular Carcinoma (Hepatoma)
07/2013 - 01/2007
3Sarcoma (Soft Tissue Sarcoma)
01/2013 - 06/2002
3Lymphoma (Lymphomas)
06/2012 - 01/2002
3Ascites
06/2012 - 01/2002
2Necrosis
01/2015 - 03/2003
2Chromosome Aberrations (Chromosome Abnormalities)
03/2013 - 10/2008
2Fibrosis (Cirrhosis)
01/2011 - 08/2010
2Neoplasm Metastasis (Metastasis)
01/2010 - 01/2007
2Leukemia
09/2009 - 01/2008
2Hyperglycemia
04/2009 - 01/2004
2Granuloma
01/2009 - 09/2008
1Occupational Stress
06/2016
1Fatigue
06/2016
1Hemorrhage
01/2015
1Papilloma (Papillomatosis)
01/2014
1Acute Kidney Injury (Acute Renal Failure)
01/2013
1Heart Neoplasms
04/2010
1Coronary Disease (Coronary Heart Disease)
04/2010
1Liver Diseases (Liver Disease)
04/2010
1Obesity
04/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
04/2010
1Melanoma (Melanoma, Malignant)
01/2010
1Anemia
09/2009
1Infections
09/2009

Drug/Important Bio-Agent (IBA)

8AntioxidantsIBA
01/2016 - 08/2002
7Ethanol (Ethyl Alcohol)IBA
01/2017 - 08/2003
5LuteinIBA
01/2016 - 01/2008
5EnzymesIBA
01/2015 - 01/2007
5Carotenoids (Carotene)IBA
07/2013 - 01/2012
4CarrageenanIBA
07/2015 - 02/2009
4Dextrans (Dextran)FDA Link
07/2015 - 02/2009
4Formaldehyde (Formol)FDA Link
07/2015 - 02/2009
4meso-zeaxanthinIBA
03/2013 - 01/2010
4Calendula extractIBA
01/2010 - 09/2008
4AlloxanIBA
04/2009 - 07/2002
3CurcuminIBA
06/2016 - 01/2007
3Hydroxyproline (4 Hydroxyproline)IBA
01/2011 - 01/2010
3gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA
01/2010 - 04/2006
2Volatile Oils (Essential Oils)IBA
01/2016 - 01/2015
2Glutathione (Reduced Glutathione)IBA
03/2015 - 01/2015
2CatalaseIBA
03/2015 - 01/2015
2Superoxide DismutaseIBA
03/2015 - 01/2015
2Diethylnitrosamine (N-Nitrosodiethylamine)IBA
07/2013 - 01/2007
2Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2013 - 07/2006
2MethylcholanthreneIBA
01/2013 - 06/2002
2Cisplatin (Platino)FDA LinkGeneric
01/2013 - 07/2012
2Indicators and Reagents (Reagents)IBA
01/2011 - 08/2010
2HexosaminesIBA
01/2010 - 01/2009
2Metalloproteases (Metalloproteinases)IBA
01/2010 - 01/2007
2Antiviral Agents (Antivirals)IBA
09/2009 - 01/2008
2Glutamic Acid (Glutamate)FDA Link
03/2009 - 01/2007
2Transaminases (Aminotransferases)IBA
03/2009 - 01/2007
2Pyruvic Acid (Pyruvate)IBA
03/2009 - 01/2007
2Alkaline PhosphataseIBA
03/2009 - 01/2007
2Oxaloacetic Acid (Oxalacetic Acid)IBA
03/2009 - 01/2007
2kutkinIBA
01/2008 - 03/2003
2AbrinIBA
01/2006 - 01/2002
2Methanol (Carbinol)IBA
08/2003 - 08/2002
1Acetic Acid (Vinegar)FDA LinkGeneric
01/2017
1Dietary FiberFDA Link
06/2016
1Glutathione PeroxidaseIBA
01/2015
1anthraceneIBA
01/2014
1Croton OilIBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
06/2012
1Terpenes (Terpenoids)IBA
10/2011
1Superoxides (Superoxide)IBA
08/2010
1TeaIBA
04/2010
1Aniline HydroxylaseIBA
01/2010
1pentoxyresorufinIBA
01/2010
1resorufinIBA
01/2010
1N-Acetylneuraminic Acid (Sialic Acid)IBA
01/2010
1CytokinesIBA
01/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2010
1methoxyresorufin-O-demethylaseIBA
01/2010
1Interleukin-6 (Interleukin 6)IBA
01/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2010
1N-Demethylating OxidoreductasesIBA
01/2010
1Uronic AcidsIBA
01/2010
1Matrix Metalloproteinases (MMPs)IBA
01/2010
1Interleukin-2 (IL2)IBA
01/2010
1Tissue Inhibitor of Metalloproteinase-1IBA
01/2010
1Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2010
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
01/2010
1Protein-Lysine 6-Oxidase (Lysyl Oxidase)IBA
01/2010
1Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2010
1AminesIBA
01/2010
1Caspase 3 (Caspase-3)IBA
06/2009
1Alanine Transaminase (SGPT)IBA
03/2009
1Biomarkers (Surrogate Marker)IBA
03/2009
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
03/2009

Therapy/Procedure

13Oral Administration
01/2016 - 07/2002
3Therapeutics
10/2011 - 12/2002
2Aftercare (After-Treatment)
10/2008 - 07/2007